02.16.2019 Issue 159

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

Head of Economic Modelling

The Head of Economic Modelling will be a key member of our senior management team and will lead our growing team of talented economic modellers.

Cardiovascular Medical Content Writer with AMCP Dossier and HEOR Knowledge

Senior Market Access Writer, Market Access Communications

Senior Consultant, Market Access Consulting

Associate Scientific Director/Director, Market Access Communications

Provider Contract/Cost of Care Consultant Sr - PS16029

Medical Statistician

Medical Writer / Literature Review Scientist

Senior Health Economics & Real-World Evidence (HE-RWE) Scientist

Health Economics & Real-World Evidence (HE-RWE) Scientist

ICER Sets Out Against Unjustified Price Increases in New Report

IQVIA’s Doyle Talks Shared Value Across All Stakeholders

Leonard Discusses NPC’s Response to HHS RFI

Tufts Medical Center Announces New Center

Industry Spotlight

Conferences Webinars
18th Annual International Publication Planning Meeting
    February 20-21, San Diego, California

12th Annual Oncology Market Access Strategy Summit
    February 20-21, San Francisco, California

2019 Population Health Management Summit
    February 21-22, Miami, Florida

2019 Hospital Observation Patient Management Summit
    February 21-22, Miami, Florida

Clinical Statistics for Non-Statisticians
    February 27

Is the New Congress Ready to Lower Drug Costs?
    February 27

Amplifying the Patient Voice: Policy Solutions for Improving Patient-Reported Measures in Oncology Value-Based Payment Programs
    February 28

ICER: Payer Perspectives on the Use and Usage of ICER Reports
    February 28

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Innovative Drugs: Mapping the Pricing and Reimbursement Landscape

Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

Blockchain: Transformational Change for Pharma?

2018 Specialty Drug Trends

The Global Use of Medicine in 2019 and Outlook to 2023

Breaking Through the Hype of Real-World Evidence

Time to Market: Accelerating Market Access

Orphan Drugs in the United States

Charting Real World Data and Evidence – Activity and Capabilities (2018)

Special Thanks to Our Partners:
          Evidera    HealthCore    University of FL   Xcenda
      OM1    Parexel    Jefferson    Dymaxium   Precision Xtract    
      Pharmerit    eMax Health    Sciformix   Evidence Partners    ICON